跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,006 条关于
“Transcenta Holding”
全部
3,006
临床试验
1,945
药物
70
机构
259
资讯
732
2年前
Transcenta Announces Positive Interim Results, Highlights Osemitamab and Blosozumab Progress
上个月
Transcenta Sells Hangzhou CDMO Plant to WuXi Biologics for RMB 190 Million, Then Licenses HiCB Platform Back to the Buyer
去年
Lupus Nephritis Pipeline Shows Strong Activity with 35+ Companies Developing 40+ Investigational Therapies
去年
Gastric Cancer Pipeline Shows Robust Growth with 220+ Therapies in Development Across 200+ Companies
8个月前
Transcenta Therapeutics Partners with EirGenix to License Continuous Biomanufacturing Platform for Affordable Biologics
9天前
Transcenta Licenses HiCB Continuous Bioprocessing Platform to WuXi Biologics in Strategic CMC Collaboration
去年
IgA Nephropathy Pipeline Shows Robust Growth with 30+ Therapies in Development
2年前
Osemitamab Plus Nivolumab and CAPOX Shows Encouraging Efficacy in G/GEJ Cancer
去年
Scholar Rock's Apitegromab Shows Promise in SMA, Faces Financial and Development Hurdles
去年
Oculis Holding Gains Buy Ratings Based on Promising Pipeline and Market Potential
第 1 页,共 74 页
上一页
下一页